Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes

Keyphrases

• Systolic Blood Pressure 100%
• Type 2 Diabetes Mellitus (T2DM) 100%
• Blood Pressure 100%
• Chronic Kidney Disease 100%
• Cardiorenal Outcomes 100%
• Finerenone 100%
• Treatment Effect 28%
• Composite Outcome 28%
• Kidney 28%
• FIDELIO-DKD 28%
• Hypertension 14%
• Placebo 14%
• Cardiovascular Outcomes 14%
• Type 2 Diabetic Patients 14%
• Estimated Glomerular Filtration Rate 14%
• Kidney Disease Progression 14%
• Kidney Disease 14%
• Time-varying Analysis 14%
• Disease Progression 14%
• Diabetic Kidney Disease 14%
• Unique Identifier 14%
• Controlled Blood Pressure 14%
• Failure Progression 14%
• Primary Key 14%
• Kidney Failure 14%
• Urinary Albumin-to-creatinine Ratio 14%
• Nonsteroidal Mineralocorticoid Receptor Antagonist 14%

Medicine and Dentistry

• Systolic Blood Pressure 100%
• Blood Pressure 100%
• Maturity Onset Diabetes of the Young 100%
• Chronic Kidney Disease 100%
• Finerenone 100%
• Treatment Effect 28%
• Cardiovascular System 28%
• Placebo 14%
• Patient with Type 2 Diabetes 14%
• Nephropathy 14%
• Glomerular Filtration Rate 14%
• Diabetic Nephropathy 14%
• Creatinine 14%
• Renal Failure 14%
• Disease Exacerbation 14%
• Mineralocorticoid Antagonist 14%
• Albumin 14%
• Hypertension 14%